8.2.6: Clinical Trials

Advancing Clinical Trials: Building the European Clinical Trials Engine

Project brief

This task focuses on establishing a collaborative network to support clinical trial activities across Cancer Centers and CCCs. The initiative prioritises equal access to clinical trials for patients throughout Europe by building a robust infrastructure for cross-border collaboration. By streamlining trial processes, sharing best practices, and developing patient-centred educational materials, the network will boost European clinical trials capacities.

Objectives (Summary)

  • Ensure Equitable Access to Clinical Trials For Patients in Europe
  • Foster Cross-Border Collaboration and Knowledge Exchange
  • Enhance Europe's role in the global clinical trial landscape
  • Streamline Clinical Trial Management

Lead

View the teams and institutions involved in this task.

Karolinska University Hospital

Sweden

VHIO

Spain

ULSSM

Portugal

How external partners can help

  • Share Best Practices & SOPs
  • Participate in Host Exchange Programs
  • Co-Develop Educational Resources
  • Advocate & Advocate

Our activities

Survey & Bottleneck Mapping - Conduct a targeted survey of Cancer Centers to identify existing processes, hurdles, and resource gaps in clinical-trial management.

Clinicial Trial Management Resource Center - centralized platform to collect, structure, and share SOPs, guidelines, and best practices, supporting standardized trial processes across Europe

Exchange Programs for Trial Professionals - Pair institutions and staff - trial coordinators, data managers, research nurses – to rotate between centers, learning best practices in trial setup, monitoring, and reporting.

Expert Working Groups - Launch thematic expert interactive online meetings (e.g. Cross-border collaboration, Academic Clinical Trials) to share challenges and discuss solutions; and set up an Expert Q&A Platform to address real world clinical trial questions.

Educational Materials for Patients - Provide multimedia toolkits that explain trial design, informed consent, and co-creation opportunities—empowering patients to participate or co-design studies.

Industry & Stakeholder Engagement - Host roundtables with pharma, biotech, and academic sponsors to showcase EUnetCCC’s unified infrastructure and encourage them to partner on academically led or industry-sponsored trials.

Video presentation

Contact

Other tasks

8.2.7

Cancer Survivorship

8.2.8

Governance, Organisation and Leadership

Latest Insights & Updates

Explore our newest blog posts featuring key developments, expert insights, and innovations in comprehensive cancer care.

WP8 Video Series August 01, 2026

World Lung Cancer Day: what everyone should know

Lung cancer is one of the leading causes of cancer death in the European Union. It accounts for one in five cancer deaths and 12% of all new cancer cases. It is the second most diagnosed cancer in men and the third in women.

WP8 Video Series July 23, 2026

Voices from the patient community

In this video, Andreea Breaz, patient representative at the Oncology Institute "Prof. Dr. Ion Chiricuță" (Romania), and Miguel Reis, cancer survivor and member of the Patient Advisory Council at IPO Porto (Portugal), share why patients must be active partners in shaping cancer care, what helps them feel heard and the kind of support that matters most beyond treatment.

WP8 Video Series July 16, 2026

The EUnetCCC Cancer Prevention Hub: a framework for integrating personalized prevention into Comprehensive Cancer Centres

We are pleased to share the teaser video following the first EUnetCCC Work Package 8 (WP8) Teaming Workshop, hosted at Centre Léon Bérard (CLB) in Lyon.